Health-related quality-of-life measurement in hypertension: A review of randomised controlled drug trials

PharmacoEconomics

Volumn 18, Issue 5, 2000, Pages 435-450

  Cote, I ^a   Gregoire, J P ^a   Moisan, J ^a  

^a LAVAL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ALTIZIDE; AMLODIPINE; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; CAPTOPRIL; CHLORTALIDONE; CILAZAPRIL; CLOPAMIDE; DILTIAZEM; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; DOXAZOSIN; ENALAPRIL; FELODIPINE; HYDROCHLOROTHIAZIDE; ISRADIPINE; LISINOPRIL; NICARDIPINE; NIFEDIPINE; NITRENDIPINE; QUINAPRIL; RAMIPRIL; SPIRONOLACTONE; UNINDEXED DRUG; VASODILATOR AGENT; VERAPAMIL;

ADVERSE DRUG REACTION; ARTICLE; CLINICAL TRIAL; DRUG TOLERABILITY; HUMAN; HYPERTENSION; MEASUREMENT; MENTAL HEALTH; PATIENT COMPLIANCE; PERCEPTION; PRIORITY JOURNAL; QUALITY OF LIFE; SEXUAL FUNCTION; SLEEP DISORDER; SOCIAL INTERACTION; WELLBEING;

EID: 0033778018     PISSN: 11707690     EISSN: None     Source Type: Journal    
DOI: 10.2165/00019053-200018050-00003     Document Type: Article

References (104)

1. The effects of antihypertensive therapy on the quality of life
2. Developing a model for the study of quality of life in elderly patients with chronic disease: Use of hypertension as an example
3. Quality of life: A model for evaluating health for all. Conceptual considerations and policy implications
4. Applying quality of life data in practice: Considerations for antihypertensive therapy
5. Assessment of quality-of-life outcomes
6. The MOS 36-items short-form health survey (SF-36): I: Conceptual framework and item selection
7. The sickness impact profile: Development and final revision of a health status measure
8. Generic and disease-specific measures in assessing health status and quality of life
9. Health related utility measurement: An introduction
10. Methodology for measuring health-state preferences - II: Scaling methods
11. Valuing health-related quality of life. A review of health state valuation techniques
12. Measuring health-related quality of life in rheumatoid arthritis: Validity, responsiveness and reliability of EUROQOL (EQ-5D)
13. Evaluating health-related quality-of-life outcomes in patients with congestive heart failure
14. Quality of life comparison between bisoprolol and nifedipine retard in hypertension
15. Relationships of quality-of-life measures to long-term lifestyle and drug treatment in the treatment of mild hypertension study
16. Alpha-blockade and thiazide treatment of hypertension. A double-blind randomized trail comparing doxazosin and hydrochlorothiazide
17. Effect of blood pressure control and antihypertensive drug regimen on quality of life: The African American Study of Kidney Disease and Hypertension (AASK) Pilot Study
18. Efficacy and tolerance of antihypertensive treatment in men and women with stage 1 diastolic hypertension. Results of the Treatment of Mild Hypertension Study
19. Quality of life in hypertensive patients treated with either carvedilol or enalapril
20. A randomized comparison of the effect of four antihypertensive monotherapies on the subjective quality of life in previously untreated asymptomatic patients: Field trial in general practice. The OCAPI Study Group
21. Comparison of a lifestyle modification program with propranolol use in the management of diastolic hypertension
22. Ramipril vs captopril in mild to moderate hypertension
23. Comparison of verapamil and captopril in elderly hypertensive subjects: Results of a randomized, double-blind, crossover study
24. Effect of hydrochlorothiazide, enalapril, and propranolol on quality of life and cognitive and motor function in hypertensive patients
25. Treatment of mild hypertension study. Final results. Treatment of Mild Hypertension Study Research Group
26. The Treatment of Mild Hypertension Study: A randomized, placebo-controlled trial of a nutritional-hygienic regimen along with various drug monotherapies
27. Nicardipine as antihypertensive monotherapy: Positive effects on quality of life
28. A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension. The Primary Pulmonary Hypertension Study Group
29. Quality of life before and during antihypertensive treatment: A comparative study of celiprolol and atenolol
30. Quality of life in normotensives compared to hypertensive men treated with isradipine or methyldopa as monotherapy or in combination with captopril: The LOMIR-MCT-IL study
31. The impact of diuretic therapy on reported sexual function
32. Does lowering the blood pressure improve the mood? Quality-of-life results from the Hypertension Optimal Treatment (HOT) study
33. The effects of replacing beta-blockers with an angiotensin converting enzyme inhibitor on the quality of life of hypertensive patients
34. Hypertension in the elderly: 24 H ambulatory blood pressure results from a placebo-controlled trial
35. Evaluation and quality-of-life assessment of amlodipine and enalapril in patients with hypertension
36. Impact of the treatment of isolated systolic hypertension on behavioral variables. Results from the Systolic Hypertension in the Elderly Program
37. Effects of antihypertensive medications on quality of life in elderly hypertensive women
38. Effects of 100 mg of controlled-release metoprolol and 100 mg of atenolol on blood pressure, central nervous system-related symptoms, and general well being
39. Doxazosin and captopril in mildly hypercholesterolemic hypertensive patients. The Doxazosin-Captopril in Hypercholesterolemic Hypertensives Study
40. Quality of life and antihypertensive therapy in men. A comparison of captopril with enalapril
41. Parallel perspectives on quality of life during antihypertensive therapy: Impact of responder, survey environment, and questionnaire structure
42. Quality of life with three antihypertensive treatments: Cilazapril, atenolol, nifedipine
43. Quality of life on antihypertensive therapy: A double-blind trial comparing quality of life on pinacidil and nifedipine in combination with a thiazide diuretic. European Pinacidil Study Group
44. Superiority of nonpharmacologic therapy compared to propranolol and placebo in men with mild hypertension: A randomized, prospective trial
45. Quality of life in hypertensives treated with atenolol or captopril: A double-blind crossover trial
46. Impact of diagnosis and treatment of hypertension on quality of life: A double-blind, randomized, placebo-controlled, cross-over study of betaxolol
47. A randomized controlled trial of the effects of three antihypertensive agents on blood pressure control and quality of life in older women
48. Aspects of quality of life on treatment with felodipine
49. The effects of two centrally-acting anti-hypertensive drugs on the quality of life
50. Quality of life, side effects and efficacy of lisinopril compared with metoprolol in patients with mild to moderate essential hypertension
51. The effects of antihypertensive agents on the quality of life in Indian hypertensives
52. Assessment of quality of life by patient and spouse during antihypertensive therapy with atenolol and nifedipine gastrointestinal therapeutic system
53. Quality of life among hypertensive patients with a diuretic background who are taking atenolol and enalapril
54. Hypertensive black men and women. Quality of life and effects of antihypertensive medications. Black hypertension quality of life multicenter trial group
55. Quality of life on antihypertensive therapy: A randomized double-blind controlled trial of captopril and atenolol
56. Antihypertensive regimen and quality of life in a disadvantaged population
57. A comparison of verapamil and nifedipine on quality of life
58. Antihypertensive therapy and quality of life: A comparison of atenolol, captopril, enalapril and propranolol
59. The effects of verapamil and propranolol on quality of life in hypertension
60. Comparison of enalapril and atenolol in mild to moderate hypertension
61. Short-term behavioral effects of beta-adrenergic medications in men with mild hypertension
62. Sexual symptoms in hypertensive patients. A clinical trial of antihypertensive medications
63. No difference in general well-being during antihypertensive treatment with atenolol or metoprolol CR
64. Comparison of quality of life on nitrendipine and propranolol
65. Effects of antihypertensive medications on vitality and well-being
66. Disparate effects of initial antihypertensive therapy on well-being
67. Angiotensin converting enzyme inhibitors and quality of life: The European trial
68. Additive effects of diltiazem and lisinopril in the treatment of elderly patients with mild-to-moderate hypertension
69. Main results of the losartan versus amlodipine (LOA) study on drug tolerability and psychological general well-being. LOA Study Group
70. Analysis of adverse effects among patients with essential hypertension receiving an ACE inhibitor or a beta-blocker
71. Low dosages of felodipine ER once daily as monotherapy in elderly hypertensive patients: Effect on ambulatory blood pressure and quality of life
72. Additive effects of verapamil and enalapril in the treatment of mild to moderate hypertension
73. Low-dose drug combination therapy: An alternative first-line approach to hypertension treatment
74. Efficacy and safety of atenolol, enalapril, and isradipine in elderly hypertensive women
75. Nebivolol in hypertension: A double-blind placebo-controlled multicenter study assessing its antihypertensive efficacy and impact on quality of life
76. Effects of diltiazem and metoprolol on blood pressure, adverse symptoms and general well-being. The Swedish Diltiazem-Metoprolol Multi-Centre Study Group
77. Antihypertensive efficacy and tolerability of enalapril and slow-release verapamil in essential hypertension: A double-blind, cross-over study
78. Well being and its measurement in hypertension. A randomized, double-blind cross-over comparison of 5 mg clopamide with 25 mg hydrochlorothiazide
79. Swedish Isradipine Study in Hypertension: Evaluation of quality of life, safety, and efficacy
80. Lisinopril and nifedipine in essential hypertension: A Norwegian multicenter study on efficacy, tolerability and quality of life in 828 patients
81. Efficacy and influence on quality of life of enalapril as a first step treatment of hypertension
82. Candesartan cilexetil is not associated with cough in hypertensive patients with enalapril-induced cough. Multicentre Cough Study Group
83. Comparison of losartan and hydrochlorothiazide on cognitive function and quality of life in hypertensive patients
84. Physical Symptoms Distress Index: A sensitive tool to evaluate the impact of pharmacological agents on quality of life
85. The effects of propranolol on cognitive function and quality of life: A randomized trial among patients with diastolic hypertension
86. Losartan improves exercise tolerance in patients with diastolic dysfunction and a hypertensive response to exercise
87. Impact of antihypertensive treatment on quality of life: Comparison between bisoprolol and bendrofluazide
88. Effect of long-term treatment with antihypertensive drugs on quality of life of elderly patients with hypertension: A double-blind comparative study between a calcium antagonist and a diuretic. NICS-EH Study Group. National Intervention Cooperative Study in Elderly Hypertensives
89. Bisoprolol and nifedipine retard in elderly hypertensive patients: Effect on quality of life
90. Improved quality of life in patients with generalized cardiovascular metabolic disease on a prepared diet
91. Efficacy, tolerability, and quality of life of losartan, alone or with hydrochlorothiazide, versus nifedipine GITS in patients with essential hypertension
92. Long-term cost-effectiveness of various initial monotherapies for mild to moderate hypertension
93. Health-related quality-of-life measurement in patients with Parkinson's disease
94. A review of quality of life in Alzheimer's disease
95. Quality-of-life considerations in the treatment of asthma
96. Quality of life in cystic fibrosis
97. Health-related quality-of-life evaluation in HIV-infected patients
98. A comparative review of pharmacoeconomic guidelines
99. Cross-cultural validation of existing quality of life scales
100. A comparative review of generic quality-of-life instruments
101. Social interaction tests and scales
102. International use and application of generic health-related quality of life instruments